Clinical Trial Update: Effect of Aspirin on Hemostatic and Vascular Function After Live Fire Fighting [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update examining the effect of aspirin on hemostatic and vascular function after live fire fighting; completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Risk Factors
• Vascular Functional or Late Conditions

Drugs mentioned

• Aspirin (Aspirin)

Snippet

Sponsor: University of Illinois at Urbana-Champaign | Conditions: Cardiovascular Risk Factor, C.Medical Procedure; Vascular, Functional or Late | Phase 4 | Status: COMPLETED